EGFR and colorectal carcinoma: This method uses a real-time polymerase chain reaction to detect the methylation of 16 CpG sites in bisulfite-treated genomic DNA of RAS wild-type advanced recurrent CRC patients who received third-line anti-EGFR antibody therapy.